List view / Grid view
25 May 2016 | By Victoria White, Digital Content Producer
The findings may lead to new therapeutic strategies and suggest limitations to therapies designed to eliminate amyloid plaques from Alzheimer's patient's brains...
25 May 2016 | By Victoria White, Digital Content Producer
MJFF is to fund two projects leveraging the promise of engineered stem cells to speed new therapies and deeper understanding of Parkinson's disease...
25 May 2016 | By Victoria White, Digital Content Producer
TwoXAR is to collaborate with the Department of Medicine at the University of Chicago to identify potential new medicines for treating atherosclerosis...
25 May 2016 | By Victoria White, Digital Content Producer
Thunderbolt is the first company established by Vitesse Biologics, a unique collaboration model formed by Baxalta, Mayo Clinic and VPD...
25 May 2016 | By Victoria White, Digital Content Producer
The company’s lead product Cilcane (generic name cilengitide) is being repurposed by Iceni as a first-in-class treatment for multiple myeloma...
24 May 2016 | By Victoria White, Digital Content Producer
Conspiracy theories and pseudoscientific claims refuting the facts around Zika virus vaccines could be putting people at risk, according to a new study...
24 May 2016 | By Victoria White, Digital Content Producer
Delamanid could also be a powerful tool to combat visceral leishmaniasis researchers at the University of Dundee have found...
23 May 2016 | By Victoria White, Digital Content Producer
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer's disease, according to new research...
23 May 2016 | By Victoria White, Digital Content Producer
Researchers have identified a protein 'brake' within Natural Killer cells that controls their ability to destroy their target tumour cells...
23 May 2016 | By Victoria White, Digital Content Producer
Harvard researchers have created a new platform for antibiotic discovery that, they say, may go a long way to solving the crisis of antibiotic resistance...
23 May 2016 | By Victoria White, Digital Content Producer
The new funding will enable DefiniGEN to deliver ground-breaking cryopreserved pancreatic beta cell products to the global diabetes drug development market...
23 May 2016 | By Victoria White, Digital Content Producer
Boehringer Ingelheim and BioMed X have established a research team that will conduct research to identify new treatment approaches for psychiatric diseases...
20 May 2016 | By Mandy Parrett, Editorial Assistant
Osaka University and Chugai Pharmaceutical Co., Ltd. announce details of their collaborative agreement for advanced research into immunology.
19 May 2016 | By SMI
SMi are thrilled to have Dr Carl Dolman from the National Institute for Biologics, Standard and Control (NIBSC), a centre of the MHRA, present an opening keynote at the 3rd annual Allergies conference when it returns to London on 6th & 7th July...
18 May 2016 | By Katie Sadler
A trial funded by the Medical Research Council has found psilocybin, the active ingredient in magic mushrooms, reduced depressive symptoms.
